Shalby Share Price

170.621.69 (1.01%)

Closed
As On: 15 Jun, 2026, 03:49 PM IST
As On: 15 Jun, 2026, 03:40 PM IST

Sector: Hospitals & All...
Industry: Hospital

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	171.70
High	173.25
Low	169.42
Prev Close	168.93
Volume	66,648
VWAP(₹)	170.83

Share Price	Value
Today/Current/Last	170.62171.35
Previous Day	168.93169.10

Shalby Share Recommendations

Mean recosCurrent

BUY

1 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	-	-	-	-
Buy	1	1	1	1
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	1	1

Recent Recos

Target₹180
OrganizationICICI Direct
BUY

Target₹180
OrganizationICICI Direct
BUY

Target₹150
OrganizationICICI Direct
BUY

View all Stock Recommendations

News & Analysis

Profit Turnaround: These 5 stocks surged up to 57% after swinging to black. Do you own any?
News
These 9 healthcare stocks record their 52-week high, gain up to 58% in a month
News
For risk takers: 5 smallcap stocks that have beaten volatile markets can rise up to 58%
News
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcements

View all Shalby Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	279.35	289.91	303.43	270.21	281.05
Total Income Growth (%)	-3.64	-4.46	12.29	-3.86	2.31
Total Expenses	259.48	261.19	271.41	260.28	258.04
Total Expenses Growth (%)	-0.65	-3.77	4.28	0.87	2.51
EBIT	19.87	28.72	32.02	9.93	23.01
EBIT Growth (%)	-30.81	-10.32	222.47	-56.84	0.19
Profit after Tax (PAT)	1.77	8.38	8.92	-11.02	-1.81
PAT Growth (%)	-78.94	-6.03	-	-	-153.42
EBIT Margin (%)	7.11	9.91	10.55	3.68	8.19
Net Profit Margin (%)	0.63	2.89	2.94	-4.08	-0.65
Basic EPS (₹)	0.12	0.68	0.71	-1.13	-0.28

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	221.02	229.78	242.18	214.20	226.92
Total Income Growth (%)	-3.81	-5.12	13.06	-5.61	4.30
Total Expenses	195.59	194.93	199.49	185.86	188.06
Total Expenses Growth (%)	0.34	-2.28	7.34	-1.17	0.79
EBIT	25.42	34.84	42.69	28.34	38.86
EBIT Growth (%)	-27.04	-18.37	50.62	-27.07	25.44
Profit after Tax (PAT)	13.79	19.75	25.70	14.96	20.86
PAT Growth (%)	-30.19	-23.12	71.77	-28.28	20.32
EBIT Margin (%)	11.50	15.16	17.63	13.23	17.12
Net Profit Margin (%)	6.24	8.60	10.61	6.98	9.19
Basic EPS (₹)	1.28	1.84	2.39	1.39	1.94

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,114.55	953.18	827.44	711.37	439.96
Total Revenue Growth (%)	16.93	15.20	16.32	61.69	-12.75
Total Expenses	1,058.82	824.99	725.40	627.79	384.90
Total Expenses Growth (%)	28.34	13.73	15.55	63.10	-13.99
Profit after Tax (PAT)	6.22	84.08	67.70	54.13	42.40
PAT Growth (%)	-92.60	24.19	25.08	27.67	53.68
Operating Profit Margin (%)	8.68	15.44	13.81	12.80	13.61
Net Profit Margin (%)	0.57	9.00	8.41	7.74	9.83
Basic EPS (₹)	0.18	7.78	6.31	5.00	3.92

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	899.13	850.39	727.38	659.80	428.29
Total Revenue Growth (%)	5.73	16.91	10.24	54.06	-14.62
Total Expenses	763.39	692.08	606.03	555.44	372.79
Total Expenses Growth (%)	10.30	14.20	9.11	48.99	-16.15
Profit after Tax (PAT)	83.79	103.85	80.81	69.81	42.88
PAT Growth (%)	-19.31	28.51	15.76	62.79	53.30
Operating Profit Margin (%)	16.82	19.42	17.57	16.55	14.11
Net Profit Margin (%)	9.60	12.51	11.41	10.78	10.24
Basic EPS (₹)	7.80	9.67	7.52	6.46	3.97

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 3.42% of its operating revenues towards interest expenses and 16.5% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,703.65	1,607.53	1,281.36	1,193.54	996.62
Total Assets Growth (%)	5.98	25.45	7.36	19.76	3.10
Total Liabilities	708.33	599.75	353.75	317.36	161.96
Total Liabilities Growth (%)	18.10	69.54	11.46	95.96	-3.27
Total Equity	995.33	1,007.79	927.62	876.17	834.67
Total Equity Growth (%)	-1.24	8.64	5.87	4.97	4.44
Current Ratio (x)	1.45	1.71	2.66	2.61	3.32
Total Debt to Equity (x)	0.43	0.31	0.15	0.18	0.04
Contingent Liabilities	62.85	24.42	24.65	212.11	79.52

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,469.80	1,373.99	1,167.37	1,087.38	1,012.37
Total Assets Growth (%)	6.97	17.70	7.36	7.41	3.16
Total Liabilities	335.81	311.81	197.05	180.66	162.72
Total Liabilities Growth (%)	7.70	58.24	9.07	11.03	-2.89
Total Equity	1,133.99	1,062.18	970.32	906.72	849.65
Total Equity Growth (%)	6.76	9.47	7.01	6.72	4.41
Current Ratio (x)	3.89	3.99	3.89	3.69	3.36
Total Debt to Equity (x)	0.09	0.11	0.03	0.05	0.04
Contingent Liabilities	384.47	170.80	157.93	201.32	78.86

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	-4.34	19.60	67.78	18.92	84.35
Net Cash used in Investing Activities	-35.64	38.07	-61.08	-60.28	-56.97
Net Cash flow from Financing Activities	47.58	-150.69	-50.02	90.46	-29.36
Net Cash Flow	7.61	14.94	-43.31	49.10	-1.98
Closing Cash & Cash Equivalent	34.79	27.18	12.24	55.58	6.49
Closing Cash & Cash Equivalent Growth (%)	27.98	121.99	-77.97	756.99	-23.37
Total Debt/ CFO (x)	-98.28	16.02	2.09	8.19	0.42

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	148.82	139.77	164.53	100.98	82.45
Net Cash used in Investing Activities	-100.63	-206.01	-172.40	-40.32	-57.54
Net Cash flow from Financing Activities	-35.80	72.14	-38.21	-17.25	-27.32
Net Cash Flow	12.40	5.91	-46.09	43.41	-2.41
Closing Cash & Cash Equivalent	21.60	9.20	3.30	49.44	6.02
Closing Cash & Cash Equivalent Growth (%)	134.65	178.99	-93.33	720.80	-28.60
Total Debt/ CFO (x)	0.69	0.82	0.15	0.41	0.43

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 97.28 cr for investing activities which is an YoY increase of 172.99%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	0.62	8.40	7.29	6.17	5.07
Return on Capital Employed (%)	7.56	11.22	10.22	8.76	6.41
Return on Assets (%)	0.36	5.23	5.28	4.53	4.25
Interest Coverage Ratio (x)	4.14	12.25	17.44	22.43	16.21
Asset Turnover Ratio (x)	0.66	0.65	0.60	0.62	43.23
Price to Earnings (x)	344.83	30.58	21.37	23.31	25.71
Price to Book (x)	2.15	2.57	1.56	1.44	1.30
EV/EBITDA (x)	15.76	14.58	9.88	9.87	10.91
EBITDA Margin (%)	14.73	21.04	19.78	18.93	22.15

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	7.38	9.77	8.32	7.69	5.04
Return on Capital Employed (%)	10.89	12.73	11.73	10.82	6.35
Return on Assets (%)	5.70	7.55	6.92	6.41	4.23
Interest Coverage Ratio (x)	16.71	68.70	52.09	51.13	16.48
Asset Turnover Ratio (x)	0.61	0.65	0.63	0.62	41.35
Price to Earnings (x)	25.45	24.81	17.89	18.08	25.45
Price to Book (x)	1.88	2.42	1.49	1.39	1.28
EV/EBITDA (x)	11.90	13.49	9.08	8.40	10.88
EBITDA Margin (%)	21.28	23.89	22.81	22.04	22.86

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Shalby	49.29	1.83	3.71	7.87	2.03	12.05	8.72	3.03	3.23	1.25	0.54	-67,452.25
Krishna Instt of Medical Sciences	127.61	12.04	10.74	8.35	3.11	20.68	13.95	6.13	6.03	0.76	1.44	6.35
Rainbow Childrens	51.76	8.66	16.88	16.88	10.03	13.05	25.68	16.53	27.41	3.59	0.00	0.00
Dr. Agarwals Health	104.49	6.57	6.57	9.70	3.37	26.93	16.23	8.08	4.21	1.24	0.08	0.30
Healthcare Global	679.72	6.64	1.03	8.48	0.35	14.45	9.68	0.83	0.97	1.12	0.68	2.62
Add More

Annual Ratios (%)

Choose from Peers

Jupiter Life Line Hospitals
Yatharth Hospital
Artemis Medicare
Indraprastha Med
Sakar Healthcare

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Shalby Stock Performance	1.01	6.80	7.01	9.19	-15.44	23.55	5.78
Krishna Instt of Medical Sciences Stock Performance	-1.95	-0.45	13.00	11.17	16.16	150.41	0.00
Rainbow Childrens Stock Performance	3.93	7.78	11.16	18.51	6.35	58.33	0.00
Dr. Agarwals Health Stock Performance	-0.11	-1.56	-3.97	-1.48	12.20	0.00	0.00
Healthcare Global Stock Performance	-0.50	1.68	9.16	6.58	3.46	101.27	232.55
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	8,02,78,373	74.33 %	0.00
Pledge	0	0.00 %	0.00
FII	47,09,211	4.36 %	-0.10
DII	2,69,776	0.25 %	0.06
MF	4,776	0.00 %	0.00
Others	2,27,52,410	21.06 %	0.04

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	74.33	74.33	74.33	74.27
Pledge	0.00	0.00	0.00	0.00
FII	4.36	4.47	4.63	5.21
DII	0.25	0.19	0.19	0.19
Mutual Funds	0.00	0.00	0.00	0.00
Others	21.06	21.01	20.85	20.33

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Groww BSE Hospitals ETF-G
Equity: Sectoral-Pharma
- 0.11
  Amount Invested (in Cr.)
- 0.21014852%
  % of AUM
- 36.38
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.03%
  % of AUM
- -9.57
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.03%
  % of AUM
- 6.90
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Board Meeting
Audited Results & Final Dividend
May 11, 2026
General Meeting
-
Feb 18, 2026
Board Meeting
Quarterly Results
Feb 02, 2026

Board Meetings

Announced on	Meeting on
May 11, 2026	May 27, 2026
Audited Results & Final Dividend
Feb 02, 2026	Feb 11, 2026
Quarterly Results
Nov 06, 2025	Nov 13, 2025
Quarterly Results
Aug 05, 2025	Aug 13, 2025
Quarterly Results
May 20, 2025	May 29, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 28, 2024 Sep 19, 2024 12%
May 18, 2023 Aug 08, 2023 12%
May 25, 2022 Sep 19, 2022 10%
May 05, 2021 Sep 17, 2021 10%
Jun 15, 2020 Sep 04, 2020 5%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
May 28, 2024	Sep 19, 2024	12%
May 18, 2023	Aug 08, 2023	12%
May 25, 2022	Sep 19, 2022	10%
May 05, 2021	Sep 17, 2021	10%
Jun 15, 2020	Sep 04, 2020	5%

AGM/EGM Meetings

Announced on	Meeting on
Feb 18, 2026	Mar 23, 2026
-
Aug 20, 2025	Sep 29, 2025
-
Feb 10, 2025	Mar 16, 2025
-
Aug 23, 2024	Sep 26, 2024
Rs.1.2000 per share(12%)Final Dividend & A.G.M.
Jul 13, 2023	Aug 20, 2023
Rs.1.2000 per share(12%)Final Dividend & A.G.M.

About Shalby

Shalby Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 1,842.86 Crore) operating in Hospitals & Allied Services sector.

Shalby Ltd. key Products/Revenue Segments include Sale of services, Medicines and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 295.52 Crore, up 5.79 % from last quarter Total Income of Rs 279.35 Crore and up 9.37 % from last year same quarter Total Income of Rs 270.21 Crore. Company has reported net profit after tax of Rs 18.45 Crore in latest quarter.

The company’s top management includes Dr.Vikram Shah, Dr.Ashok Bhatia, CA.Shyamal Joshi, CA.Sujana Shah, Mr.Tej Malhotra, Dr.Umesh Menon, Mr.Vijay Kedia, Mr.Amit Pathak, Mr.Tushar Shah. Company has T R Chadha & Co. as its auditors. As on 31-03-2026, the company has a total of 10.80 Crore shares outstanding.

Shalby Share Price Today is Rs. 170.62. On previous day, the Shalby Share Price (NSE) closed at Rs. 164.52, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 74.33% of the stake in Shalby shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Shalby stocks was 4.36% as compared to 4.47% in Dec 2025 with decrease of 0.11%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.25% as compared to 0.19% in Dec 2025 with increase of 0.06%. Out of the total DII holdings in Shalby shares 0.0% was held by mutual funds. The rest including public held is 21.06%. Shalby stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Shalby Dividend: Ever since 2004, Shalby dividends has been paid out around 6 times. As on 15 Jun, 2026, 03:49 PM IST, The overall dividend yield for Shalby stands at 0.0%. The last dividend paid was on September 19, 2024 (Rs. 1.2). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 3.46.

Shalby Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 295.52 Cr. of sales and 5.79% of quarterly net profit, there have been multiple ups and downs in the Shalby stock prices in the past few weeks. For example, Shalby stock price on 5th of June 2026 was around Rs. 173.8. Shalby share price now stands at an average of Rs. 170.62. Judging by last week's performance, stock is in down trend.

Shalby has a median target price of Rs. 192.0 in 12 months by 1 analysts. They have provided a high estimate of Rs. 192.0 and low estimate of Rs. 192.0 for Shalby share.

Historical Prices and Performance:
Shalby, incorporated in 2004 is a Small Cap company (with a market cap of Rs. 1824.61) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Shalby stock was 3.71%, 0.62%, 8.4%, 7.29% and 6.17% respectively.
The Shalby share gave a 3 year return of 17.97% as compared to Nifty 50 which gave a return of 26.99%.
Shalby announced 12.0% final dividend on September 19, 2024.

Key Metrics:
PE Ratio of Shalby is 48.8
Prices/Sales Ratio of Shalby is 1.19
Price/Book Ratio of Shalby is 1.81

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Shalby, major competitors and peers include Krishna Instt of Medical Sciences, Dr. Agarwals Health, Rainbow Childrens and Healthcare Global. As of Dec 2025, the dividend yield of Shalby stands at 0.0% while Krishna Instt of Medical Sciences, Dr. Agarwals Health, Rainbow Childrens and Healthcare Global stand at 0.0%, 0.0%, 0.26% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 48.8 and 1.81 respectively.

Leadership of Shalby :
Amit Pathak is Chief Financial Officer
Tushar Shah is Co. Secretary & Compl. Officer
Vikram Shah is Chairman & Managing Director
Ashok Bhatia is Independent Director
Shyamal Joshi is Independent Director
Umesh Menon is Independent Director
Tej Malhotra is Independent Director
Sujana Shah is Independent Director
Vijay Kedia is Independent Director

Industry

Hospital

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

Shalby Multi-Specialty Hospitals,Opp. Karnavati Club,S.G. Highway,Ahmedabad, Gujarat - 380015

Contact

companysecretary@shalby.in

http://www.shalby.org

PE Ratio(x)	49.29
EPS - TTM(₹)	3.46
MCap(₹ Cr.)	1,842.86
MCap Rank	25
PB Ratio(x)	1.81
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	274.70
52W Low(₹)	125.82
MCap/Sales	1.19
Beta(1 Month)	0.67
BV/Share(₹)	93.11

PE Ratio(x)	49.50
EPS - TTM(₹)	3.46
MCap(₹ Cr.)	1,850.75
MCap Rank	25
PB Ratio(x)	1.82
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	274.50
52W Low(₹)	125.70
MCap/Sales	1.19
Beta(1 Month)	0.79
BV/Share(₹)	93.11

1 Day	1.01%
1 Month	7.91%
3 Months	18.47%
1 Year	-5.24%
3 Years	18.32%
5 Years	3.28%

1 Day	1.33%
1 Month	8.79%
3 Months	19.08%
1 Year	-4.88%
3 Years	18.87%
5 Years	3.72%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Shalby Share Price

Key Metrics